Showing results (41-50 of 535) with videos related to
Sort By:
Pageof 54
Clinical Pharmacology and Therapeutics|December 12, 2017
Emerging Innovative Therapeutic Approaches Leveraging Cyclin-Dependent Kinase Inhibitors to Treat Advanced Breast CancerMarcelo Cruz, Tomás Reinert, Massimo CristofanilliInternational Journal of Radiation Oncology, Biology, Physics|January 31, 2004
Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combinationZhaomei Mu, Paul Hachem, Sudhir Agrawal, et al.Journal of Personalized Medicine|April 3, 2021
Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors?Laura Cortesi, Claudia Piombino, Angela TossRecenti Progressi in Medicina|January 22, 2026
[Trastuzumab-deruxtecan (T-DXd) in HER2+ metastatic breast cancer: efficacy, clinical management, and perspectives.]Fabio Canino, Mario Giuliano, Angela TossCurrent Cancer Drug Targets|March 10, 2018
PARP Inhibitors for the Treatment of Ovarian CancerLaura Cortesi, Angela Toss, Iole CucinottoOncotarget|September 1, 2018
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applicationsAngela Toss, Federico Piacentini, Laura Cortesi, et al.Nature Reviews. Drug Discovery|July 18, 2002
Angiogenesis modulation in cancer research: novel clinical approachesMassimo Cristofanilli, Chusilp Charnsangavej, Gabriel N HortobagyiNature Reviews. Clinical Oncology|October 20, 2010
Molecular mechanisms of metastasis in breast cancer--clinical applicationsMichal Mego, Sendurai A Mani, Massimo CristofanilliChinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysisXiaoshen Dong, Katherine R Alpaugh, Massimo CristofanilliSeminars in Oncology|March 1, 2008
The medical treatment of inflammatory breast cancerShaheenah Dawood, Naoto T Ueno, Massimo CristofanilliPageof 54